Clinical Trials Browser

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06555263 2025-08-22

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06676917 2025-08-08

TUXEDO-5

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04615884 2025-07-28

CH:II

Phase NA Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02264236 2025-07-20

Vaccination of Advanced-Stage Lung Cancer Patients

Phase 1/2 Withdrawn

Thoracic

Lung Neoplasms

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT04214015 2025-06-05

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06494046 2025-06-04

Defining Musical Toxicity and Its Effect on Patient Well-being

Withdrawn

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT05840770 2025-05-26

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Phase 2 Withdrawn

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03877250 2025-05-15

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06522360 2025-04-24

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Lung Cancer Screening CT for Firefighters

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

INDIGO

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

CheckCell-2

ARTIA-Lung

EPIC

Neo-Kan

AI-Lung

BIB 01

EMPIRE

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

TUXEDO-5

CH:II

Vaccination of Advanced-Stage Lung Cancer Patients

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Defining Musical Toxicity and Its Effect on Patient Well-being

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)